Skip to content

Promoting Aging and Thriving With HIV

Promoting Aging and Thriving With HIV (PATH)-Implementation of a Tailored Geriatric Assessment and Management Strategy for HIV Care Settings

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07192419
Acronym
PATH
Enrollment
60
Registered
2025-09-25
Start date
2025-10-17
Completion date
2026-09-30
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric, Geriatric Assessment, HIV, HIV - Human Immunodeficiency Virus, HIV (Human Immunodeficiency Virus)

Brief summary

The pilot is an intervention of a geriatric assessment and management tool (PATH) in outpatient HIV clinics.

Detailed description

This will be a Pilot, two-arm, randomized parallel-group, clinical trial with blinded research staff of a Geriatric assessment and management tool vs usual care to evaluate the feasibility, acceptability, and preliminary efficacy of the tool on quality of life for older adults with HIV.

Interventions

BEHAVIORALPromoting Aging and Thriving with HIV (PATH)-Implementation of a Tailored Geriatric Assessment and Management Strategy for HIV Care Settings

For the intervention arm, participants will be sent geriatric assessment questions through the patient portal in advance of a routine HIV appointment. If the participant is unable to complete the questions in advance, they will be done with the help of a research coordinator to go through on the day of appointment. Every attempt will be made to ensure the assessment can be done in advance of the appointment, however the study team will allow for visits after the regular appointment as in which case the provider will receive results after the patient has left clinic. The provider will receive the PATH assessment responses and a discussion guide with suggested initial management steps. The provider ultimately determines with the participant when and if they will address concerns identified (that visit or future visit) based on participant priorities. The patient participant will also receive a copy of their screening results.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 50 or older * Receive HIV care (at least 1 visit at the same site within the past 12 months) from either Eskenazi Health IDC or LifeCare clinics, * Able to provide informed consent

Exclusion criteria

* Patients who are long-term nursing home residents * Patients who are receiving geriatric care services, however will liberalize this criteria if difficulty with recruitment

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: recruitment and retentionRecruitment day one, throughout the study to final assessment six months post baseline of the last participant.Feasibility will be measured by tracking the number of participants approached, enrolled, retained, observations by study team throughout study.
Feasibility: patient/provider experienceAfter completing final outcomes at the 6 month assessment (or earlier if difficulty with recruitment/retention) patients and providers will be invited to participate in an optional qualitative interview.Feasibility will be measured by qualitative Interviews with patients and providers. Interview questions will be used to derive personal anecdotes of the patient/provider experience pertaining to the feasibility of the study.
Acceptability; General attitudes, perception of interventionAfter completing final outcomes at the 6 month assessment (or as needed if difficulty with recruitment/retention) patients and providers will be invited to participate in an optional qualitative interview.Acceptability will be measured by qualitative Interviews with patients and providers. Interview questions will be used to derive personal anecdotes of the patient/provider general attitudes, perception of intervention.

Secondary

MeasureTime frameDescription
Impact of PATH Outcomes: measured by identification of geriatric conditionsGeriatric Conditions will be measured through chart review at baseline, 3month, and 6 month assessments to determine overall change from baseline.To evaluate the impact of PATH HIV Outcomes the study will look at change from baseline in patient geriatric conditions. This study hypothesizes that compared to usual care, PATH participants will have more geriatric conditions identified and managed as compared to baseline geriatric conditions.
Impact of PATH Outcomes: measured by addressing unmet needs.Unmet needs will be measured through survey questions and chart review at baseline, 3month, and 6 month assessments.Evaluate the impact of PATH HIV on addressing unmet needs of older adults living with HIV. This study hypothesizes that compared to usual care, PATH participants will have more psychosocial needs addressed compared to the number of unmet needs at baseline.
Quality of life as measured by Medical Outcomes 36-Item Short Form Survey (SF-36)Quality of life will be measures at baseline, 3 months and 6 months post baseline assessments.Evaluate the preliminary impact of PATH on health-related quality of life for older adults with HIV using the Medical Outcomes 36-Item Short Form Survey (SF-36). This study hypothesizes that compared to usual care, intervention recipients will have improved quality of life as measured by SF-36. The SF-36 includes eight scales measuring domains of physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. These scores can be combined into a Mental Component Summary Score and a Physical Component Summary Score. Component summary scores range from 0 (poor) to 100 (excellent) with the higher scores representing higher physical/mental health respectively.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026